These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 30300411)

  • 1. Antimicrobial treatment practices among Ugandan children with suspicion of central nervous system infection.
    Kemigisha E; Nanjebe D; Boum Y; Langendorf C; Aberrane S; Nyehangane D; Nackers F; Mueller Y; Charrel R; Murphy RA; Page AL; Mwanga-Amumpaire J
    PLoS One; 2018; 13(10):e0205316. PubMed ID: 30300411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasmid-mediated AmpC beta-lactamase-producing Escherichia coli causing urinary tract infection in the Auckland community likely to be resistant to commonly prescribed antimicrobials.
    Drinkovic D; Morris AJ; Dyet K; Bakker S; Heffernan H
    N Z Med J; 2015 Mar; 128(1410):50-9. PubMed ID: 25829039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Control of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a children's hospital by changing antimicrobial agent usage policy.
    Lee J; Pai H; Kim YK; Kim NH; Eun BW; Kang HJ; Park KH; Choi EH; Shin HY; Kim EC; Lee HJ; Ahn HS
    J Antimicrob Chemother; 2007 Sep; 60(3):629-37. PubMed ID: 17599919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bloodstream infections by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in children: epidemiology and clinical outcome.
    Kim YK; Pai H; Lee HJ; Park SE; Choi EH; Kim J; Kim JH; Kim EC
    Antimicrob Agents Chemother; 2002 May; 46(5):1481-91. PubMed ID: 11959586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence, phylogeny, and antimicrobial resistance of Escherichia coli pathotypes isolated from children less than 5 years old with community acquired- diarrhea in Upper Egypt.
    Khairy RMM; Fathy ZA; Mahrous DM; Mohamed ES; Abdelrahim SS
    BMC Infect Dis; 2020 Dec; 20(1):908. PubMed ID: 33256619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular characteristics and antibiotic resistance profiles of Escherichia coli strains isolated from urinary tract infections in children admitted to children's referral hospital of Qom, Iran.
    Pourakbari B; Mamishi S; Shokrollahi MR; Heydari H; Mahmoudi S; Banar M; Sadeghi RH; Movahedi Z
    Ann Ig; 2019; 31(3):252-262. PubMed ID: 31069370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Previous Antibiotic Exposure Increases Risk of Infection with Extended-Spectrum-β-Lactamase- and AmpC-Producing Escherichia coli and Klebsiella pneumoniae in Pediatric Patients.
    Zerr DM; Miles-Jay A; Kronman MP; Zhou C; Adler AL; Haaland W; Weissman SJ; Elward A; Newland JG; Zaoutis T; Qin X
    Antimicrob Agents Chemother; 2016 Jul; 60(7):4237-43. PubMed ID: 27139486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High prevalence of NDM metallo-β-lactamase among ESBL-producing Escherichia coli İsolates.
    Çetinkol Y; Sandalli C; Çalgin MK; Yildirim AA; Akyildiz E; Karaman E; Çiçek AÇ
    Acta Microbiol Immunol Hung; 2017 Jun; 64(2):131-141. PubMed ID: 28420242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High prevalence of multidrug resistant ESBL- and plasmid mediated AmpC-producing clinical isolates of Escherichia coli at Maputo Central Hospital, Mozambique.
    Estaleva CEL; Zimba TF; Sekyere JO; Govinden U; Chenia HY; Simonsen GS; Haldorsen B; Essack SY; Sundsfjord A
    BMC Infect Dis; 2021 Jan; 21(1):16. PubMed ID: 33407206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of extended-spectrum beta-lactamase on acute pyelonephritis treated with empirical ceftriaxone.
    Lee S; Song DY; Cho SH; Kwon KT
    Microb Drug Resist; 2014 Feb; 20(1):39-44. PubMed ID: 23941639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and patient related factors associated with Extended-Spectrum Beta-Lactamase producing Escherichia coli and Klebsiella pneumoniae carriage and infection among pediatric patients in Tanzania.
    Letara N; Ngocho JS; Karami N; Msuya SE; Nyombi B; Kassam NA; Skovbjerg S; Åhren C; Philemon R; Mmbaga BT
    Sci Rep; 2021 Nov; 11(1):22759. PubMed ID: 34815472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial resistance including Extended Spectrum Beta Lactamases (ESBL) among E. coli isolated from kenyan children at hospital discharge.
    Tornberg-Belanger SN; Rwigi D; Mugo M; Kitheka L; Onamu N; Ounga D; Diakhate MM; Atlas HE; Wald A; McClelland RS; Soge OO; Tickell KD; Kariuki S; Singa BO; Walson JL; Pavlinac PB
    PLoS Negl Trop Dis; 2022 Mar; 16(3):e0010283. PubMed ID: 35358186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Cessation of Ceftiofur and Substitution with Lincomycin-Spectinomycin on Extended-Spectrum-β-Lactamase/AmpC Genes and Multidrug Resistance in Escherichia coli from a Canadian Broiler Production Pyramid.
    Verrette L; Fairbrother JM; Boulianne M
    Appl Environ Microbiol; 2019 Jul; 85(13):. PubMed ID: 31028030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Caretaker knowledge, attitudes, and practices (KAP) and carriage of extended-spectrum beta-lactamase-producing E. coli (ESBL-EC) in children in Quito, Ecuador.
    Marusinec R; Kurowski KM; Amato HK; Saraiva-Garcia C; Loayza F; Salinas L; Trueba G; Graham JP
    Antimicrob Resist Infect Control; 2021 Jan; 10(1):2. PubMed ID: 33407927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology and antimicrobial susceptibility profiles of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae and Escherichiacoli in China.
    Wang Y; Zhang Q; Jin Y; Jin X; Yu J; Wang K
    Braz J Microbiol; 2019 Jul; 50(3):669-675. PubMed ID: 30972583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of community-onset healthcare-associated and hospital-acquired urinary infections caused by extended-spectrum beta-lactamase-producing Escherichia coli and antimicrobial activities.
    Saltoglu N; Karali R; Yemisen M; Ozaras R; Balkan II; Mete B; Tabak F; Mert A; Hondur N; Ozturk R
    Int J Clin Pract; 2015 Jul; 69(7):766-70. PubMed ID: 25683907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No association between resistance mutations, empiric antibiotic, and mortality in ceftriaxone-resistant Escherichia coli and Klebsiella pneumoniae bacteremia.
    Heng ST; Chen SL; Wong JGX; Lye DC; Ng TM
    Sci Rep; 2018 Aug; 8(1):12785. PubMed ID: 30143706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibiotic Prophylaxis Is Associated with Subsequent Resistant Infections in Children with an Initial Extended-Spectrum-Cephalosporin-Resistant Enterobacteriaceae Infection.
    Das S; Adler AL; Miles-Jay A; Kronman MP; Qin X; Weissman SJ; Burnham CA; Elward A; Newland JG; Selvarangan R; Sullivan KV; Zaoutis T; Zerr DM
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28289030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficacy of non-carbapenem antibiotics for the treatment of community-onset acute pyelonephritis due to extended-spectrum β-lactamase-producing Escherichia coli.
    Park SH; Choi SM; Chang YK; Lee DG; Cho SY; Lee HJ; Choi JH; Yoo JH
    J Antimicrob Chemother; 2014 Oct; 69(10):2848-56. PubMed ID: 24928854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infections due to Escherichia coli producing extended-spectrum beta-lactamase among hospitalised patients: factors influencing mortality.
    Peña C; Gudiol C; Calatayud L; Tubau F; Domínguez MA; Pujol M; Ariza J; Gudiol F
    J Hosp Infect; 2008 Feb; 68(2):116-22. PubMed ID: 18226420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.